Folgen

  • GLP-1 Muscle Loss — Uncover the hidden risk with Dr. Ben Synth

    GLP-1 Muscle Loss — Uncover the hidden risk with Dr. Ben Synth
    Apr 7 2026
    Join Dr. Ben Synth as he uncovers the hidden cost of GLP-1 drugs like Ozempic and Mounjaro—your muscle mass. Discover the science behind muscle loss, explore next-generation therapies to prevent it, and learn practical strategies to protect lean tissue while shedding pounds.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    1 Min.
  • GLP-1 Muscle Loss — The Hidden Risk - Your Survival Guide for Protecting Muscle on Ozempic

    GLP-1 Muscle Loss — The Hidden Risk - Your Survival Guide for Protecting Muscle on Ozempic
    Apr 7 2026
    Host Ben Synth examines research showing two-thirds of GLP-1 weight loss can be muscle, not fat. This episode covers evidence-based strategies to preserve muscle during Ozempic, Wegovy, or Mounjaro treatment: resistance training protocols, protein timing, hydration, and multidisciplinary care. Learn why exercise prevents weight regain after stopping medication.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    25 Min.
  • GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug

    GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug
    Apr 7 2026
    Host Ben Synth explores groundbreaking research on GLP-1 weight loss drugs and muscle preservation. He examines the BELIEVE study combining semaglutide with bimagrumab, which achieved 92.8% fat loss versus lean tissue loss, and discusses revolutionary continuous biosensor technology tracking muscle breakdown in real-time for patients on medications like Ozempic and Mounjaro.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    25 Min.
  • GLP-1 Muscle Loss - The 40% Problem Your Doctor Might Not Mention

    GLP-1 Muscle Loss - The 40% Problem Your Doctor Might Not Mention
    Apr 7 2026
    Host Ben Synth explores the hidden cost of GLP-1 medications like Ozempic and Wegovy: up to 40% of weight lost may be muscle, not fat. Drawing from real-world research and clinical trials, this episode examines muscle preservation strategies, including resistance training and protein-rich diets, as prescriptions surge 587% nationwide.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    23 Min.
  • GLP-1 Muscle Loss — The Hidden Risk - Uncover what your medication isn't telling you with Dr. Ben Synth

    GLP-1 Muscle Loss — The Hidden Risk - Uncover what your medication isn't telling you with Dr. Ben Synth
    Apr 7 2026
    Join Dr. Ben Synth as he uncovers the hidden truth behind GLP-1 weight loss drugs: you're not just losing fat, you're losing muscle. This eye-opening series reveals the science pharmaceutical companies don't advertise and breakthrough strategies involving protein optimization, training protocols, and futuristic therapies that could revolutionize sustainable weight loss.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    1 Min.
  • GLP-1 Muscle Loss — The Hidden Risk - Bimagrumab, Biosensors, and Smarter Weight Loss

    GLP-1 Muscle Loss — The Hidden Risk - Bimagrumab, Biosensors, and Smarter Weight Loss
    Apr 7 2026
    Ben Synth explores groundbreaking research combining semaglutide with bimagrumab, which produced 22% weight loss—93% from fat while preserving muscle. Plus, emerging wearable sensors could soon monitor muscle breakdown in real-time, revolutionizing how we approach GLP-1 therapy and body composition.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    28 Min.
  • GLP-1 Muscle Loss — The Hidden Risk - The Exercise and Protein Playbook

    GLP-1 Muscle Loss — The Hidden Risk - The Exercise and Protein Playbook
    Apr 7 2026
    Ben Synth explores the Danish study showing GLP-1 patients regained two-thirds of lost weight without exercise. He breaks down the evidence-backed protein and strength training protocol that prevents up to 40% muscle loss during weight reduction, covering timing strategies, resistance training frequency, and why body composition matters more than scale numbers on semaglutide or tirzepatide.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    23 Min.
  • GLP-1 Muscle Loss — The Hidden Risk - The Vanishing 40 Percent Your Scale Can't See

    GLP-1 Muscle Loss — The Hidden Risk - The Vanishing 40 Percent Your Scale Can't See
    Apr 7 2026
    Ben Synth examines GLP-1 drugs like Ozempic and Mounjaro, revealing that up to 40% of weight loss can be muscle, not fat. He explores the science behind this hidden cost, who's most at risk, and evidence-based strategies—protein timing, resistance training, emerging therapies—to protect lean mass while pursuing weight loss goals.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    24 Min.